©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 112924
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.112924
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.112924
Figure 2 Receiver operating characteristic curve analysis to evaluate the predictive value of each inflammatory biomarker for overall survival in all recruited patients with colorectal cancer.
A: C-reactive protein/albumin ratio; B: Neutrophil-to-lymphocyte ratio; C: Platelet-to-lymphocyte ratio; D: Systemic immune-inflammation index. CAR: C-reactive protein/albumin ratio; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; SII: Systemic immune-inflammation index; AUC: Area under the curve.
- Citation: Kong FF, Geng X, Liu RM, Zhang WT, Quan B, Zhong Y, Zhu YL. Post-chemotherapy C-reactive protein/albumin ratio predicts prognosis in stage II-III colorectal cancer. World J Gastrointest Surg 2026; 18(2): 112924
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/112924.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.112924